Repligen (RGEN) Profit After Tax Growth (1y) (2011 - 2026)
Repligen (RGEN) Profit After Tax Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 17.19% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -112.01% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -62.38% |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 9.23% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 16.84% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -90.51% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -222.12% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 20.96% |
| 10 | Repligen | 7.37 Bn | 6.39 Bn | 108.28 Mn | -132.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -132.74% |
| Dec 31, 2025 | 127.34% |
| Sep 30, 2025 | 2,014.37% |
| Jun 30, 2025 | 253.11% |
| Mar 31, 2025 | 219.24% |
| Dec 31, 2024 | -144.63% |
| Sep 30, 2024 | -103.86% |
| Jun 30, 2024 | -69.29% |
| Mar 31, 2024 | -82.01% |
| Dec 31, 2023 | -140.76% |
| Sep 30, 2023 | -23.89% |
| Jun 30, 2023 | -60.09% |
| Mar 31, 2023 | -60.98% |
| Dec 31, 2022 | 380.61% |
| Sep 30, 2022 | -33.62% |
| Jun 30, 2022 | -5.21% |
| Mar 31, 2022 | 59.47% |
| Dec 31, 2021 | -48.53% |
| Sep 30, 2021 | 130.20% |
| Jun 30, 2021 | 128.44% |